Our Pricing

Lowest Price Weight Loss Injections UK - From £135.00

Published on: June 03, 2026

Searching for the lowest price weight loss injections UK with transparent upfront costs? At Cured Pharmacy, we offer genuine UK-licensed weight loss injections including Mounjaro from £135.00, Wegovy from £135.00, and Saxenda from £135.00, all with free clinical consultation by UK-registered prescribers. Every price is displayed before your consultation begins, ensuring complete transparency throughout your treatment journey.

How Weight Loss Injections Work: GLP-1 and Dual-Agonist Treatments

Weight loss injections available through UK pharmacies work by mimicking natural hormones that regulate appetite, blood sugar, and metabolism. The most commonly prescribed treatments contain GLP-1 receptor agonists such as semaglutide (found in Wegovy) and liraglutide (found in Saxenda), or the newer dual GIP/GLP-1 receptor agonist tirzepatide (Mounjaro) [1].

These medications slow gastric emptying, reduce appetite signals to the brain, and improve insulin sensitivity. In the STEP 1 trial, participants using semaglutide achieved an average body weight reduction of 14.9% over 68 weeks, whilst the SURMOUNT-1 trial demonstrated that tirzepatide produced up to 22.5% average weight reduction at the highest dose over 72 weeks [1][2].

All prescription weight loss injections require clinical assessment by a UK-registered prescriber to ensure suitability, proper dosing, and ongoing monitoring for potential side effects.

Who Can Use Weight Loss Injections?

NICE guidelines recommend GLP-1 treatments for adults with a BMI of 30 or above, or 27 or above with weight-related health conditions such as type 2 diabetes, hypertension, or sleep apnoea [3]. Your UK prescriber will assess your medical history, current medications, and weight loss goals during your free online consultation to determine the most appropriate treatment option.

Mounjaro (Tirzepatide): The UK's First Dual-Agonist Weight Loss Treatment

Mounjaro contains tirzepatide, the first medication licensed in the UK that activates both GIP and GLP-1 receptors simultaneously. This dual mechanism produces greater weight reduction compared to single-pathway GLP-1 treatments in head-to-head clinical trials [4].

The SURPASS-2 trial directly compared tirzepatide against semaglutide 1mg in patients with type 2 diabetes. At 40 weeks, participants on the highest tirzepatide dose (15mg) achieved 5.5kg greater weight loss on average than those on semaglutide [4]. When used specifically for weight management in the SURMOUNT trials, tirzepatide demonstrated average reductions of 15.0%, 19.5%, and 20.9% of body weight at the 5mg, 10mg, and 15mg doses respectively over 72 weeks [2].

Mounjaro is administered as a once-weekly subcutaneous injection using a pre-filled KwikPen device. Treatment begins at 2.5mg weekly for four weeks, then increases gradually to minimise gastrointestinal side effects. At Cured Pharmacy, Mounjaro starts from £135.00 per month, with your final dose determined by your UK prescriber based on efficacy and tolerability.

Wegovy and Saxenda: Proven GLP-1 Weight Loss Injections

Wegovy contains semaglutide, a GLP-1 receptor agonist that has been extensively studied in the STEP clinical trial programme. Across multiple trials involving over 4,500 participants, Wegovy demonstrated consistent average weight reductions of 12-17% when combined with lifestyle modifications [1]. Wegovy is administered once weekly, starting at 0.25mg and gradually increasing to a maintenance dose of 2.4mg over 16-20 weeks.

Saxenda contains liraglutide, an earlier-generation GLP-1 treatment that requires daily injection rather than weekly administration. In the SCALE trial programme, participants achieved an average 8% body weight reduction over 56 weeks [5]. Whilst the weight loss magnitude is generally lower than newer agents, Saxenda remains a clinically effective option for patients who prefer daily dosing or have contraindications to other treatments.

Both medications are MHRA-licensed for weight management in adults with a BMI of 30 or above, or 27 or above with weight-related comorbidities. Your UK prescriber will consider factors including your lifestyle, injection preference, medical history, and budget when recommending the most suitable option during your consultation.

Expected Results and Treatment Duration

Clinical trials demonstrate that most weight loss occurs within the first 6-12 months of treatment, with results plateauing thereafter. NICE recommends continuing treatment only if patients achieve at least 5% weight loss after 6 months, and many prescribers use this threshold to assess treatment response [3]. Your UK prescriber will schedule regular reviews to monitor progress, adjust dosing, and determine optimal treatment duration based on your individual response.

Comparing Weight Loss Injection Costs: What Affects UK Pricing

Weight loss injection pricing in the UK varies significantly between pharmacies due to differences in sourcing, consultation fees, and business models. At Cured Pharmacy, we display all prices upfront before your consultation begins, ensuring complete transparency with no hidden consultation charges or subscription fees.

Several factors influence the cost of weight loss injections. Manufacturing complexity affects base pricing—dual-agonist medications like Mounjaro typically cost more than single-pathway GLP-1 treatments due to newer patent protection and production processes. Dosing frequency also impacts monthly costs: weekly injections generally prove more economical than daily alternatives when comparing equivalent treatment periods.

UK pharmacy regulations require all prescription weight loss injections to include clinical assessment by a registered prescriber. Some pharmacies bundle consultation fees into medication costs, whilst others charge separately. At Cured Pharmacy, your free online consultation with a UK prescriber is included, and you only pay for your medication if deemed clinically appropriate. Our superintendent pharmacist Tarun Kumar (GPhC 2233073) personally oversees dispensing to ensure every patient receives genuine UK-licensed medicines.

Orlistat: The UK's Licensed Oral Weight Loss Alternative

For patients who prefer not to use injections, orlistat offers a clinically proven oral alternative. Unlike GLP-1 treatments that work through appetite regulation, orlistat is a lipase inhibitor that prevents approximately 30% of dietary fat from being absorbed in the digestive system [6].

Orlistat is available in two strengths: 120mg (prescription-only, available as Xenical or generic orlistat) and 60mg (available over-the-counter as Alli or Orlos). Clinical trials demonstrate that prescription-strength orlistat combined with a reduced-calorie diet produces an average 5-10% body weight reduction over 12 months [6]. The medication requires three-times-daily dosing with meals containing fat.

Common side effects relate to orlistat's mechanism of action and include oily stools, increased bowel movements, and flatulence, particularly when consuming high-fat meals. These effects can be minimised by following a lower-fat diet. At Cured Pharmacy, prescription-strength orlistat starts from £135.00, whilst over-the-counter options begin from £135.00, making it the most economical weight loss medication option for suitable patients.

Choosing Between Injectable and Oral Weight Loss Treatments

Your UK prescriber will consider multiple factors when recommending between injectable GLP-1 treatments and oral orlistat, including your BMI, weight loss goals, medical history, lifestyle, and budget. Injectable treatments generally produce greater average weight loss but require weekly or daily injections and cost more. Orlistat suits patients seeking a lower-cost oral option who are committed to dietary fat restriction and can tolerate gastrointestinal side effects.

How to Access the Lowest Price Weight Loss Injections UK Through Cured Pharmacy

Accessing prescription weight loss injections through Cured Pharmacy takes under three minutes. Start by completing our free online clinical assessment, which asks about your medical history, current medications, weight loss goals, and any contraindications. Our UK-registered prescribers review every assessment individually—we never use automated approvals for prescription medications.

If a weight loss injection is deemed clinically appropriate, your prescriber will recommend the most suitable treatment and dose based on your assessment. You'll see the exact price before confirming your order, with no hidden fees or subscription commitments. All medications are dispensed from our GPhC-registered pharmacy (registration number 9012511) in discreet, unmarked packaging.

Your medication typically arrives within 1-2 working days via Royal Mail tracked delivery. Every order includes detailed patient information leaflets, injection technique guidance, and access to our pharmacy team for ongoing support. We provide free follow-up consultations to adjust dosing, manage side effects, or switch treatments if needed. Our transparent pricing model means the lowest price weight loss injections UK are accessible without compromising on clinical safety or pharmaceutical standards.

Scientific References

1. Wilding, J. P. H., Batterham, R. L., Calanna, S., et al. (2021). Once-Weekly Semaglutide in Adults with Overweight or Obesity. New England Journal of Medicine, 384(11), 989–1002. https://doi.org/10.1056/NEJMoa2032183 [accessed 13 August 2026]
2. Jastreboff, A. M., Aronne, L. J., Ahmad, N. N., et al. (2022). Tirzepatide Once Weekly for the Treatment of Obesity. New England Journal of Medicine, 387(3), 205–216. https://doi.org/10.1056/NEJMoa2206038 [accessed 13 August 2026]
3. National Institute for Health and Care Excellence. (2023). Obesity: identification, assessment and management (CG189). NICE. https://www.nice.org.uk/guidance/cg189 [accessed 13 August 2026]
4. Frías, J. P., Davies, M. J., Rosenstock, J., et al. (2021). Tirzepatide versus Semaglutide Once Weekly in Patients with Type 2 Diabetes. New England Journal of Medicine, 385(6), 503–515. https://doi.org/10.1056/NEJMoa2107519 [accessed 13 August 2026]
5. Pi-Sunyer, X., Astrup, A., Fujioka, K., et al. (2015). A Randomized, Controlled Trial of 3.0 mg of Liraglutide in Weight Management. New England Journal of Medicine, 373(1), 11–22. https://doi.org/10.1056/NEJMoa1411892 [accessed 13 August 2026]
6. Torgerson, J. S., Hauptman, J., Boldrin, M. N., & Sjöström, L. (2004). XENical in the prevention of diabetes in obese subjects (XENDOS) study: a randomized study of orlistat as an adjunct to lifestyle changes for the prevention of type 2 diabetes in obese patients. Diabetes Care, 27(1), 155–161. https://doi.org/10.2337/diacare.27.1.155 [accessed 13 August 2026]
7. NHS. (2026). Tirzepatide: a medicine to manage type 2 diabetes and treat obesity. https://www.nhs.uk/medicines/tirzepatide/ Accessed 13 August 2026.
8. NHS. (2026). Overweight and obesity in adults. https://www.nhs.uk/conditions/overweight-and-obesity/ Accessed 13 August 2026.
9. NHS England. (2026). Weight management injections. https://www.england.nhs.uk/ourwork/prevention/obesity/medicines-for-obesity/weight-management-injections/ Accessed 13 August 2026.

Information on this page is for educational purposes only and is not medical advice. All prescription treatments require clinical assessment by a UK-registered prescriber. Always consult a qualified healthcare professional before starting any new medication. Individual results may vary, and weight loss outcomes depend on multiple factors including adherence to treatment, dietary modifications, and physical activity levels.